Alain Heroux
  • Professor
  • Medical Director, Heart Failure and Heart Transplantation
  • Cardiology
Heart Failure, Heart Transplant, Left Ventricular Assist Devices
Board Certifications
  • Cardiovascular Disease - Subspecialty Cert: The Royal College of Surgeons of England
  • Internal Medicine - General Cert: The Royal College of Surgeons of England

Incidence of fractures after cardiac and lung transplantation: a single center experienceHariman,A.; Alex,C.; Heroux,A.; Camacho,P.Journal of osteoporosis 2014 ;2014( ):573041

The Value of Psychosocial Factors in Patient Selection and Outcomes after Heart TransplantationCoglianese,E. E.; Samsi,M.; Liebo,M. J.; Heroux,A. L.Current heart failure reports 2014 ; ( ):

Regulation of connective tissue growth factor gene expression and fibrosis in human heart failureKoshman,Y. E.; Patel,N.; Chu,M.; Iyengar,R.; Kim,T.; Ersahin,C.; Lewis,W.; Heroux,A.; Samarel,A. M.Journal of cardiac failure 2013 ;19(4):283-294

Variations in institutional staffing and clinical practice are predictive of center-specific 1-year survival post-transplantVan Bakel,A. B.; Brown,R. N.; Nikolaidis,L. A.; Heroux,A.; Law,K.; Naftel,D. C.; Cardiac Transplant Research Database GroupThe Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation 2013 ;32(12):1196-1204

Left ventricular assist device-induced coagulation and platelet activation and effect of the current anticoagulant therapy regimenAshbrook,M.; Walenga,J. M.; Schwartz,J.; Heroux,A.; Jeske,W. P.; Escalante,V.; Bakhos,M.Clinical and applied thrombosis/hemostasis : official journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis 2013 ;19(3):249-255

Incidence, risk factors, and clinical outcomes of atrial fibrillation and atrial flutter after heart transplantation.Dasari,T. W.; Pavlovic-Surjancev,B.; Patel,N.; Williams,A. A.; Ezidinma,P.; Rupani,A.; Sinacore,J. L.; Heroux,A. L.American Journal of Cardiology 2010 ;106(5):737-741

Symptom frequency and distress from 5 to 10 years after heart transplantation.Grady,K. L.; Wang,E.; Higgins,R.; Heroux,A.; Rybarczyk,B.; Young,J. B.; Pelegrin,D.; Czerr,J.; Kobashigawa,J.; Chait,J.; Naftel,D. C.; White-Williams,C.; Myers,S.; Kirklin,J. K.Journal of Heart & Lung Transplantation 2009 ;28(8):759-768

Gemella morbillorum prosthetic valve endocarditis.Al Chekakie,M. O.; Heroux,A.; Montpetit,M.; Nemeh,H.Congestive Heart Failure 2009 ;15(6):291-292

Factors associated with non-adherence to therapy with warfarin in a population of chronic heart failure patients.Pamboukian,S. V.; Nisar,I.; Patel,S.; Gu,L.; McLeod,M.; Costanzo,M. R.; Heroux,A.Clinical cardiology 2008 ;31(1):30-34

Outcomes of bare metal versus drug-eluting stents in allograft vasculopathy.Reddy,P. R.; Gulati,A.; Steen,L.; Sinacore,J.; Leya,F.; Heroux,A.Journal of Heart & Lung Transplantation 2008 ;27(11):1222-1228

Patterns and predictors of physical functional disability at 5 to 10 years after heart transplantation.Grady,K. L.; Naftel,D. C.; Young,J. B.; Pelegrin,D.; Czerr,J.; Higgins,R.; Heroux,A.; Rybarczyk,B.; McLeod,M.; Kobashigawa,J.; Chait,J.; White-Williams,C.; Myers,S.; Kirklin,J. K.Journal of Heart & Lung Transplantation 2007 ;26(11):1182-1191

Medical School
  • Faculte du Medicin de l'Universite Laval
  • Universite Laval, Internal Medicine: General
  • Royal Victoria Hospital, Cardiology
  • Montreal Heart Institute, Hemodynamics and Angioplasty
  • Medical College of Virginia Hospitals, Heart Transplantation